News
Giostar, a La Jolla firm that pitches stem cell treatments to desperate patients willing to travel to Mexico to receive them, likes to portray itself as a cut above the rest. The so-called Global ...
GIOSTAR Announces FDA Approval Under Compassionate Use for a COVID-19 Clinical Trial with Stem Cells
SAN DIEGO, May 4, 2020 /PRNewswire/ -- Global Institute of Stem Cell Therapy and Research (GIOSTAR), the worldwide leader in stem cell research, is pleased to announce that they have received an ...
SAN DIEGO--(BUSINESS WIRE)--Global Institute of Stem Cell Therapy and Research, Inc. known as GIOSTAR, a San Diego, California based Global organization at the forefront of stem cell research over ...
SAN DIEGO, Dec. 10, 2019 /PRNewswire/ -- Global Institute of Stem Cell Therapy and Research (GIOSTAR), the leader in regenerative technologies, is proud to announce that they are in the process of ...
GIOSTAR is the worldwide leader in the in the field of stem cell research has its stem cell research and treatment facilities around the world. GIOSTAR is leading the way for filling the IND ...
GOLDEN, CO / ACCESSWIRE / July 14, 2020 / Vitro Diagnostics, Inc. (OTC PINK:VODG), dba Vitro Biopharma, jointly with GIOSTAR - a San Diego, California-based institution headed by Dr. Anand ...
GIOSTAR infused a 53-year-old man in a coma with Mesenchymal stem-cells taken from an umbilical cord. Prior to that, all other treatments were failing. "He was having a stroke, he was under ...
GIOSTAR is the pioneer and established leader in the field of stem cell research. Cellebration’s mission is to offer and administer stem-cell based therapies which are highly specialized to ...
GIOSTAR/HEAMGEN has developed and secured patented technology to manufacture lifesaving mature red blood cells from stem cells. The red blood cells are made utilizing a bioreactor that permits the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results